Dietary protein restriction inhibits tumor growth in human xenograft models of prostate and breast cancer

Oncotarget

Volumn 4, Issue 12, 2013, Pages 2451-2461

  Fontana, Luigi ^a,b,c   Adelaiye, Remi M ^d,e   Rastelli, Antonella L ^a   Miles, Kiersten Marie ^d   Ciamporcero, Eric ^d,f   Longo, Valter D ^g   Nguyen, Holly ^h   Vessella, Robert ^h   Pili, Roberto ^d,e  

^a WASHINGTON UNIVERSITY   (United States)

^b UNIVERSITY OF SALERNO   (Italy)

^c CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^d ROSWELL PARK CANCER INSTITUTE   (United States)

^e UNIVERSITY AT BUFFALO   (United States)

^f UNIVERSITY OF TURIN   (Italy)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^h UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

mTOR; Prostate and breast cancer; Protein restriction

Indexed keywords

KI 67 ANTIGEN; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; PROSTATE SPECIFIC ANTIGEN; SOMATOMEDIN C; TRANSCRIPTION FACTOR EZH2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER INHIBITION; CANCER TISSUE; CASTRATION RESISTANT PROSTATE CANCER; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EPIGENETICS; FEMALE; GENETIC MARKER; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN MODIFICATION; PROTEIN RESTRICTION; TUMOR XENOGRAFT;

ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; DIET, PROTEIN-RESTRICTED; DIETARY PROTEINS; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE; MICE, INBRED ICR; MICE, SCID; PLANT PROTEINS; PROSTATIC NEOPLASMS, CASTRATION-RESISTANT; RANDOM ALLOCATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84891913846     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.1586     Document Type: Article

References (36)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893-917 2.
2. Kolonel LN, Altshuler D, Henderson BE. The multiethnic cohort study: exploring genes, lifestyle and cancer risk. Nat Rev Cancer. 2004;4(7):519-27.
3. Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Mack TM. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer. 1991;63(6):963-6.
4. Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 2010;19(8):1893-907.
5. The Research Group for Population-based Cancer Registration in Japan. Cancer Incidence and Incidence Rates in Japan in 1998: Estimates Based on Data from 12 Population-based Cancer Registries. Jpn J Clin Oncol 2003; 33: 241-5.
6. Chan JM, Gann PH, Giovannucci EL. Role of diet in prostate cancer development and progression. J Clin Oncol 2005;23:8152-60.
7. Giovannucci E, Pollak M, Liu Y, Platz EA, Majeed N, Rimm EB, Willett WC. Nutritional predictors of insulin-like growth factor-1 and their relationships to cancer in men. Cancer Epidemiol Biomarkers Prev. 2003;12(2):84-9.
8. Fontana L, Weiss EP, Villareal DT, Klein S, Holloszy JO. Long-term effects of calorie or protein restriction on serum IGF-1 and IGFBP-3 concentration in humans. Aging Cell. 2008;7(5):681-7.
9. Yu H, Rohan T. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst. 2000;92(18):1472-89.
10. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science. 1998;279(5350):563-6.
11. Endogenous Hormones and Breast Cancer Collaborative Group, Key TJ, Appleby PN, Reeves GK, Roddam AW. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol. 2010;11(6):530-42.
12. Morgan TM, Koreckij TD, Corey E. Targeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathway. Curr Cancer Drug Targets. 2009;9(2):237-49.
13. Dai B, Kong YY, Ye DW, Ma CG, Zhou X, Yao XD. Activation of the mammalian target of rapamycin signaling pathway in prostate cancer and its association with patient clinicopathological characteristics. BJU Int. 2009;104(7):1009-16.
14. Ma CX, Crowder RJ, Ellis MJ. Importance of PI3-kinase pathway in response/resistance to aromatase inhibitors. Steroids. 2011;76(8):750-2.
15. Efeyan A, Zoncu R, Sabatini DM. Amino acids and mTORC1: from lysosomes to disease. Trends Mol Med. 2012;18(9):524-33.
16. Sachdev D and Yee D. Disrupting insulin-like growth factor signaling as a potential cancer therapy. Mol Cancer Ther 2007; 6(1): 1-12.
17. Pollak MN. Insulin-like growth factors and neoplasia. Norvartis Found Symp 2004;262: 84-98.
18. Corey E. and Vessella RL. Xenograft models of human prostate cancer. In: in Prostate Cancer: Biology, Genetics and the New Therapeutics, 2nd Edition; Ed. Leland Chung, William Isaacs, Jonathan Simons; Humana Press, Totowa, NJ, 2007: 3-32.
19. Xu K, Wu ZJ, Groner AC, et al. EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent. Science. 2012;338(6113):1465-9
20. Pellakuru LG, Iwata T, Gurel B, et al. Global levels of H3K27me3 track with differentiation in vivo and are deregulated by MYC in prostate cancer. Am J Pathol. 2012;181(2):560-9.
21. Norat T, Dossus L, Rinaldi S, Overvad K, Grønbaek H, et al. Diet, serum insulin-like growth factor-I and IGF-binding protein-3 in European women. Eur J Clin Nutr. 2007;61(1):91-8.
22. Nardella C, Carracedo A, Salmena L, Pandolfi PP. Faithfull modeling of PTEN loss driven diseases in the mouse. Curr Top Microbiol Immunol. 2010;347:135-68.
23. Underwood LE, Thissen JP, Lemozy S, Ketelslegers JM, Clemmons DR. Hormonal and nutritional regulation of IGF-I and its binding proteins. Horm Res.1994;42(4-5):145-51.
24. Clemmons DR, Seek MM, Underwood LE. Supplemental essential amino acids augment the somatomedin-C/insulin-like growth factor I response to refeeding after fasting. Metabolism. 1985;34(4):391-5.
25. Wang Y, Corr JG, Thaler HT, Tao Y, Fair WR, Heston WD. Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J Natl Cancer Inst. 1995;87(19):1456-62.
26. Lloyd JC, Antonelli JA, Phillips TE, et al. Effect of isocaloric low fat diet on prostate cancer xenograft progression in a hormone deprivation model. J Urol. 2010;183(4):1619-24.
27. Freedland SJ, Mavropoulos J, Wang A, Darshan M, et al. Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis. Prostate. 2008;68(1):11-9.
28. Blando J, Moore T, Hursting S, et al Dietary energy balance modulates prostate cancer progression in Hi-Myc mice. Cancer Prev Res (Phila). 2011;4(12):2002-14.
29. Moshfegh A, Goldman J, Cleveland L (2005) What we eat in America, NHANES 2001-2002: Usual nutrient intakes from food compared to Dietary Reference Intakes. http://www.ars.usda.gov/SP2UserFiles/Place/12355000/pdf/usualintaketables2001-02.pdf. Accessed Mar 23, 2013.
30. Rand WM, Pellett PL, Young VR (2003) Meta-analysis of nitrogen balance studies for estimating protein requirements in healthy adults. Am J Clin Nutr 2003;77(1): 109-27.
31. U.S. Department of the Office of the Civil Administrator of the Ryukyu Islands (1949). Records of health, education and welfare. http://www.archives.gov/research/guide-fed-records/groups/260.html
32. Willcox, B. J., Willcox, D. C., Todoriki, H., et al. Caloric restriction, the traditional Okinawan diet, and healthy aging: the diet of the world's longest-lived people and its potential impact on morbidity and life span. Annals of the New York Academy of Sciences 2007;1114: 434-455.
33. Gao X, LaValley MP, Tucker KL. Prospective studies of dairy product and calcium intakes and prostate cancer risk: a meta-analysis. J Natl Cancer Inst. 2005;97(23):1768-77.
34. Zheng S, Rollet M, Yang K, Pan YX. A gestational low-protein diet represses p21WAF1/Cip1 expression in the mammary gland of offspring rats through promoter histone modifications. Br J Nutr. 2012;108(6): 98-1007.
35. Cong R, Jia Y, Li R, et al. Maternal low-protein diet causes epigenetic deregulation of HMGCR and CYP7α1 in the liver of weaning piglets. J Nutr Biochem. 2012 Dec;23(12):1647-54.
36. Donohoe DR, Bultman SJ. Metaboloepigenetics: Interrelationships between energy metabolism and epigenetic control of gene expression. J Cell Physiol. 2012; 227(9): 3169-3177.